Cargando…

m(6)A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma

N(6)-methyladenosine [m(6)A/m(6)A] methylation is one of the most common RNA modifications in eukaryotic cell mRNA and plays an important regulatory role in mRNA metabolism, splicing, translocation, stability, and translation. Previous studies have demonstrated that the m(6)A modification is highly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hongbo, Zhao, Xiangxuan, Lu, Zaiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902930/ https://www.ncbi.nlm.nih.gov/pubmed/33643384 http://dx.doi.org/10.3389/fgene.2021.622233

Ejemplares similares

m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020)

Identification of the Signature Associated With m(6)A RNA Methylation Regulators and m(6)A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung Adenocarcinoma
por: Guo, Bingzhou, et al.
Publicado: (2021)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
por: Wang, Hongbo, et al.
Publicado: (2019)

Prognostic Implication of the m(6)A RNA Methylation Regulators in Rectal Cancer
por: Chen, Yajie, et al.
Publicado: (2021)

SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Liu, Gaohua, et al.
Publicado: (2022)

Expression and Prognostic Characteristics of m(6) A RNA Methylation Regulators in Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2020)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

The Identification of Critical m(6)A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma
por: Xu, Jiaju, et al.
Publicado: (2020)

mRBioM: An Algorithm for the Identification of Potential mRNA Biomarkers From Complete Transcriptomic Profiles of Gastric Adenocarcinoma
por: Dong, Changlong, et al.
Publicado: (2021)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Prognostic N6-methyladenosine (m6A)-related lncRNA patterns to aid therapy in pancreatic ductal adenocarcinoma
por: Wang, Yuxin, et al.
Publicado: (2022)

Identification of Potential Long Non-coding RNA Expression Quantitative Trait Methylations in Lung Adenocarcinoma and Lung Squamous Carcinoma
por: Wu, Xiaohong, et al.
Publicado: (2020)

Comprehensive circular RNA expression profile of lung adenocarcinoma with bone metastasis: Identification of potential biomarkers
por: Cai, Ying, et al.
Publicado: (2022)

Prognostic analysis of m6A-related lncRNAs as potential biomarkers in intrahepatic cholangiocarcinom
por: Shi, Guodong, et al.
Publicado: (2022)

Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis
por: Wang, Zhiqiang, et al.
Publicado: (2022)

Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma
por: Cai, Wenhan, et al.
Publicado: (2022)

Predicting the Lung Adenocarcinoma and Its Biomarkers by Integrating Gene Expression and DNA Methylation Data
por: Qiu, Wang-Ren, et al.
Publicado: (2022)

The Potential Role of m6A RNA Methylation in the Aging Process and Aging-Associated Diseases
por: Sun, Jin, et al.
Publicado: (2022)

Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma
por: Tang, Xiaomei, et al.
Publicado: (2022)

Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer
por: Yang, Shifeng, et al.
Publicado: (2022)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas
por: Mao, Kaimin, et al.
Publicado: (2023)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma
por: Li, Lei, et al.
Publicado: (2022)

Aberrant methylation of dipeptidyl peptidase‑like 6 as a potential prognostic biomarker for lung adenocarcinoma
por: Munkhjargal, Batkhishig, et al.
Publicado: (2023)

Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma
por: Chai, Xiu-kun, et al.
Publicado: (2021)

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
por: Zhao, Cui, et al.
Publicado: (2021)

Establishment and Validation of a 5 m6A RNA Methylation Regulatory Gene Prognostic Model in Low-Grade Glioma
por: Bai, Zhiqun, et al.
Publicado: (2022)

Identification of a Five-mRNA Signature as a Novel Potential Prognostic Biomarker for Glioblastoma by Integrative Analysis
por: Xu, Huifang, et al.
Publicado: (2022)

DNASE1L3 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma Based on Data Mining
por: Chen, Jianlin, et al.
Publicado: (2021)

Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma
por: Zhao, Huihui, et al.
Publicado: (2022)

Crosstalk Between Histone and m(6)A Modifications and Emerging Roles of m(6)A RNA Methylation
por: Xu, Zibin, et al.
Publicado: (2022)

Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

A Novel circRNA–miRNA–mRNA Hub Regulatory Network in Lung Adenocarcinoma
por: Zuo, Haiwei, et al.
Publicado: (2021)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
por: Wang, Guangyao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nlfghrh0btr8sp6td5tke46oaa